Cheng XY

References (6)

Title : Development of novel aza-stilbenes as a new class of selective MAO-B inhibitors for the treatment of Parkinson's disease - Knez_2024_Bioorg.Chem_153_107877
Author(s) : Knez D , Wang F , Duan WX , Hrast Rambaher M , Gobec S , Cheng XY , Wang XB , Mao CJ , Liu CF , Frlan R
Ref : Bioorg Chem , 153 :107877 , 2024
Abstract :
PubMedSearch : Knez_2024_Bioorg.Chem_153_107877
PubMedID: 39396452

Title : Development of novel aza-stilbenes as a new class of selective MAO-B inhibitors for the treatment of Parkinson's disease - Knez_2024_Bioorg.Chem_153_107877
Author(s) : Knez D , Wang F , Duan WX , Hrast Rambaher M , Gobec S , Cheng XY , Wang XB , Mao CJ , Liu CF , Frlan R
Ref : Bioorg Chem , 153 :107877 , 2024
Abstract :
PubMedSearch : Knez_2024_Bioorg.Chem_153_107877
PubMedID: 39396452

Title : Development of novel aza-stilbenes as a new class of selective MAO-B inhibitors for the treatment of Parkinson's disease - Knez_2024_Bioorg.Chem_153_107877
Author(s) : Knez D , Wang F , Duan WX , Hrast Rambaher M , Gobec S , Cheng XY , Wang XB , Mao CJ , Liu CF , Frlan R
Ref : Bioorg Chem , 153 :107877 , 2024
Abstract :
PubMedSearch : Knez_2024_Bioorg.Chem_153_107877
PubMedID: 39396452

Title : Therapeutic effects of total saikosaponins from Radix bupleuri against Alzheimer's disease - Li_2022_Front.Pharmacol_13_940999
Author(s) : Li J , Zou B , Cheng XY , Yang XH , Zhao CH , Ma RX , Tian JX , Yao Y
Ref : Front Pharmacol , 13 :940999 , 2022
Abstract :
PubMedSearch : Li_2022_Front.Pharmacol_13_940999
PubMedID: 35935875

Title : Therapeutic effects of total saikosaponins from Radix bupleuri against Alzheimer's disease - Li_2022_Front.Pharmacol_13_940999
Author(s) : Li J , Zou B , Cheng XY , Yang XH , Zhao CH , Ma RX , Tian JX , Yao Y
Ref : Front Pharmacol , 13 :940999 , 2022
Abstract :
PubMedSearch : Li_2022_Front.Pharmacol_13_940999
PubMedID: 35935875

Title : Therapeutic effects of total saikosaponins from Radix bupleuri against Alzheimer's disease - Li_2022_Front.Pharmacol_13_940999
Author(s) : Li J , Zou B , Cheng XY , Yang XH , Zhao CH , Ma RX , Tian JX , Yao Y
Ref : Front Pharmacol , 13 :940999 , 2022
Abstract :
PubMedSearch : Li_2022_Front.Pharmacol_13_940999
PubMedID: 35935875